S
Schrodinger
Physics-based computational platform for drug discovery and materials science.
About
Schrödinger provides a physics-based software platform for molecular discovery and design. Their solutions are used across life sciences and materials science to accelerate research challenges in areas like drug discovery, antibody design, and the development of new materials. The company serves industries including biotech, pharmaceutical, and academic institutions.
Tags
Company Timeline
Funding rounds, employee growth, revenue, and exits over the same period. News mentions shown as markers.
No timeline data for this period
Score Breakdown
38Traction
40Team
70Visibility
5Profile
0Community
15Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Schrodinger do?
Schrödinger provides a physics-based software platform for molecular discovery and design. Their solutions are used across life sciences and materials science to accelerate research challenges in areas like drug discovery, antibody design, and the development of new materials. The company serves industries including biotech, pharmaceutical, and academic institutions.
How much funding has Schrodinger raised?
Schrodinger has raised a total of $110M in funding. The most recent round on record is Series D.
Where is Schrodinger headquartered?
Schrodinger is headquartered in New York City, United States.
When was Schrodinger founded?
Schrodinger was founded in 1990.
What industry does Schrodinger operate in?
Schrodinger operates in AI, SaaS, Biotechnology, Drug Discovery, Materials Science.
What is Schrodinger's current status?
Schrodinger's current operating status is: Public.